Literature DB >> 15477720

Surgical treatment of endocrine pancreatic tumours.

Göran Akerström1, Per Hellman, Ola Hessman, Liliana Osmak.   

Abstract

Endocrine pancreatic tumours (EPTs) are uncommon, with a major challenge to alert physicians to their recognition and requirements of treatment. Functioning EPTs cause well-known clinical syndromes of hormone excess. Insulinomas, gastrinomas and glucagonomas are most common; vipomas and somatostatinomas are rare. EPTs also occur as non-functioning lesions without symptoms of hormone excess occasionally with ectopic hormone, such as ACTH and Cushing syndrome as a late complication. The majority of EPTs are sporadic, but they may also be part of a multiple endocrine neoplasia type 1 syndrome or rarely the von Hippel-Lindau syndrome. EPTs have been of great interest to endocrine surgeons and we have, during recent years, witnessed continuing advances in diagnosis, imaging and treatment of the different tumour entities. It has become obvious that surgical treatment of these tumours is of increased concern and can have a marked impact on symptoms and survival.

Entities:  

Mesh:

Year:  2004        PMID: 15477720     DOI: 10.1159/000080744

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  3 in total

1.  Surgical experiences of functioning neuroendocrine neoplasm of the pancreas.

Authors:  Chang Moo Kang; Se Ho Park; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee; Byong Ro Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

2.  Non-functioning, malignant pancreatic neuroendocrine tumour (PNET): a rare entity during pregnancy.

Authors:  Carsten H Kamphues; Christoph Röcken; Peter Neuhaus; Ulf P Neumann
Journal:  Langenbecks Arch Surg       Date:  2008-05-30       Impact factor: 3.445

3.  Insulinoma case series: Experience of a tertiary care center.

Authors:  Manjunath Ganesh Anakal; Pramila Kalra; Mala Dharmalingam; S Indushekhar; Venkatesh Rao; K M Prasanna Kumar
Journal:  Indian J Endocrinol Metab       Date:  2014-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.